• Macrophage-Driven Nociceptor Priming in Sleep Apnea

  2026-08-26

  This study identifies peripheral macrophage recruitment and signaling as a causal link between chronic intermittent hypoxia and persistent pain-like sensitization in mice. Its design separates hypoxia from sleep fragmentation and provides a mechanistic framework for investigating immune-targeted approaches to pain associated with obstructive sleep apnea.

• Latrunculin B as a Causal Probe of Actin Function

  2026-08-26

  Latrunculin B is more than an actin polymerization inhibitor: it can function as a causal control for separating actin-dependent phenotypes from clathrin-mediated viral entry. This article translates Wang et al.’s inhibitor-based findings into practical assay-design and interpretation strategies.

• Resiniferatoxin (RTX) Workflows for TRPV1 Pain Models

  2026-08-25

  Resiniferatoxin (RTX) combines an acute TRPV1 calcium signal with durable sensory-neuron desensitization, making it useful for pain, inflammation, and target-validation studies. This practical guide covers assay setup, route-specific model selection, workflow controls, and troubleshooting for osteoarthritis and neuropathic pain research.

• IDP-Inspired Nanocoacervates for Cytosolic Delivery

  2026-08-25

  Jin and colleagues developed intrinsically disordered protein-inspired nanovectors that assemble with biomacromolecules into adaptive nanocoacervates for direct cytosolic delivery. The platform combines physiological stability, membrane penetration driven by nanovector motion, and glutathione-triggered cargo release, supporting delivery of proteins, antibodies, mRNAs, and CRISPR components.

• PPM-18: iNOS and NF-κB Signaling Inhibitor

  2026-08-24

  PPM-18, also known as N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, is a synthetic naphthoquinone derivative that suppresses inducible nitric oxide synthase expression through NF-κB pathway inhibition. Its reported activity includes reduced nitrite formation and inflammatory signaling in macrophages, with applications in inflammation and immune response modulation and sepsis research.

• Trilaurin Workflows for Biocatalysis and Drug Delivery

  2026-08-23

  Trilaurin connects renewable-feedstock biocatalysis with lipid-based oral delivery of fragile peptide and protein drugs. This practical guide covers preparation, cascade-reaction design, solid lipid formulation, assay controls, and troubleshooting for reproducible laboratory workflows.

• Autophagy–Liver Metastasis Signature in CRC

  2026-08-22

  Bai et al. integrated bulk and single-cell transcriptomic data to develop a six-gene prognostic signature linking autophagy, liver metastasis, and immune suppression in colorectal cancer. The model was validated across independent cohorts and associated high risk with T-cell exhaustion, SPP1-positive macrophage polarization, and possible resistance to immunotherapy.

• Dabigatran Etexilate: From Mechanism to Translation

  2026-08-21

  A translational guide to Dabigatran etexilate, connecting thrombin inhibition mechanism, assay design, competitive context, and atrial fibrillation research.

• MG-132 Workflows for ROS and Apoptosis Assays

  2026-08-21

  Build reproducible MG-132 experiments around proteasome blockade, oxidative stress, apoptosis, and cell-cycle readouts. This guide also shows how to use the compound as a mechanistically distinct comparator when interpreting BRD4–ferroptosis experiments.

• CBD, FAAH, and Affective Orofacial Pain

  2026-08-20

  This 2026 study shows that cannabidiol acts across peripheral inflammatory pathways, trigeminal pain circuits, and affective networks in mouse models of orofacial and chronic inflammatory pain. Its multimodal design links FAAH and endocannabinoid changes with CB1-, CB2-, and serotonin-related mechanisms, while also identifying important limits for translating CBD findings into targeted FAAH experiments.

• ML133 HCl: Kir2.1 Assay Workflows

  2026-08-20

  ML133 HCl is a selective potassium channel inhibitor for separating Kir2.1-dependent effects from broader potassium channel activity. This workflow-focused guide applies it to pulmonary artery smooth muscle cell proliferation research, pathway validation, and cardiovascular ion channel assays while addressing pH, solubility, vehicle, and endpoint controls.

• Aconitase Activity Colorimetric Assay Kit Guide

  2026-08-19

  The Aconitase Activity Colorimetric Assay Kit converts aconitase function into a rapid 450 nm readout for TCA-cycle and oxidative damage studies. This guide explains how to interpret aconitase activity alongside the CD28–ARS2–PKM findings in CD8+ T cells without confusing glycolytic flexibility with mitochondrial function.

• Tacalcitol Monohydrate: Applied Cell Workflows

  2026-08-19

  Tacalcitol monohydrate supports reproducible VDR-focused workflows spanning keratinocyte NGF assays, psoriasis biology, and exploratory colorectal cancer studies. This guide translates published timing and concentration data into practical setup, combination-treatment, and troubleshooting decisions.

• EPZ-6438: Selective EZH2 Inhibitor Guide

  2026-08-18

  EPZ-6438 is a potent EZH2 inhibitor that competitively targets the SAM pocket and reduces H3K27me3, a repressive chromatin mark. Its nanomolar biochemical activity and activity in malignant rhabdoid tumor, EZH2-mutant lymphoma, and cervical cancer models make it a useful tool for epigenetic cancer research.

• Forskolin B1421 for Reliable Cell Assays

  2026-08-18

  Forskolin (SKU B1421) is a direct adenylate cyclase activator for controlled cAMP perturbation in viability, proliferation, and cytotoxicity workflows. This scenario-based guide addresses solvent handling, endpoint interpretation, model selection, protocol optimization, and practical supplier evaluation.

456 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page